Importantly, in the injectable trial, the pace of weight loss didn't appear to be tapering at the end of the study period, leaving open the possibility that patients could lose more weight by simply staying on the treatment longer
We focus on personalized programs that look at the whole person, not just the BMI
It is more appropriate to call diabetic complications as MDS-related target organ damage (TOD), since their development involves not only hyperglycemia but also other metabolic disorders of MDS, promoting an up-to-date management philosophy
THE SCIENCE BEHIND WEGOVY Semaglutide has been researched for more than a decade and is known to be both effective and safe
Multi-mechanism research designs
Beyond nausea, early dosing can worsen other GI symptoms